Loading clinical trials...
Loading clinical trials...
The intra-vitreous injection (IVT) of anti-VEGF (vascular endothelial growth factor) is currently the standard treatment for retinal neovascularization. The VEGF stimulates endothelial cells' prolifer...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
NCT02088151 · Macular Edema, Central Serous Chorioretinopathy, and more
NCT04650672 · Retinal Neovascularization
NCT02486484 · Neovascularization, Macular Degeneration, and more
NCT01769183 · Retinal Neovascularization
NCT02033018 · Choroidal Retinal Neovascularization
Centre Pole Vision du val d'Ouest
Lyon
Fondation Ophtalmologique A. de Rotchschild
Paris
Centre médical et chirurgical de la rétine
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions